Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu

Updated on: December 20,2023

Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu

Updated on:December 20,2023

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers

Updated on: December 20,2023

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers

Updated on:December 20,2023

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Updated on: November 20,2023

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Updated on:November 20,2023

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert

Updated on: December 20,2023

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert

Updated on:December 20,2023

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on: October 31,2023

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on:October 31,2023

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg

Updated on: December 20,2023

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg

Updated on:December 20,2023

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on: October 11,2023

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on:October 11,2023

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on: March 12,2024

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on:March 12,2024

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra

Updated on: January 08,2024

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra

Updated on:January 08,2024

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t

Updated on: October 10,2023

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t

Updated on:October 10,2023

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo

Updated on: October 12,2023

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo

Updated on:October 12,2023

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig

Updated on: October 31,2023

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig

Updated on:October 31,2023